Epilepsy News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Evidence-Based Care For Childhood Epilepsy Follows Comparative Effectiveness Trial
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy...
Study Suggests Drop In Hormone Therapy Contributed To Breast Cancer Decline, Newsweek Opinion Piece Says
While breast cancer continues to be the second most common cancer among women in the U.S., "rates have been declining by about 2% a year since 1999, after having increased for the previous 20 years," Newsweek contributing editor Barbara Kantrowitz and Washington correspondent Pat Wingert write in a opinion piece...
Evidence-Based Treatment For Childhood Epilepsy
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy the most common form of epilepsy in kids has established an evidence-based approach for initial drug therapy...
Mayo Clinic Designated Top Epilepsy Treatment Center
Mayo Clinic has been designated a comprehensive epilepsy treatment center by the National Association of Epilepsy Centers (NAEC). Only the top epilepsy programs - those that can provide the most complex and advanced care - are selected for this designation, according to the association...
Lacosamide Validated As Promising Therapy For Uncontrolled Partial-Onset Seizures
A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients. Researchers from the Barrow Neurological Institute, St...
Neural Mechanism May Underlie An Enhanced Memory For The Unexpected
The human brain excels at using past experiences to make predictions about the future. However, the world around us is constantly changing, and new events often violate our logical expectations. "We know these unexpected events are more likely to be remembered than predictable events, but the underlying neural mechanisms for these effects remain unclear," says lead researcher, Dr...
Health Minister Calls For Regional Epilepsy Champions In Health Trusts
Health minister Ann Keen MP has today called for primary care trusts and strategic health authorities to "identify an epilepsy champion who can drive a local review of epilepsy services and put in place an implementation plan to commission world-class epilepsy services"...
Scientists Discover Clues To Human Diseases By Studying Dolphins In A Changing Ocean
A panel of governmental, academic and non-profit scientists speaking at the annual meeting of the American Association for the Advancement of Science (AAAS) unveiled research suggesting that diseases found in dolphins are similar to human diseases and can provide clues into how human health might be affected by exposure to contaminated coastal water or seafood...
High-Fat Ketogenic Diet To Control Seizures Is Safe Over Long Term
Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center...
First Aid For Seizures Portrayed Inaccurately On Popular TV Dramas
New research from Canada shows that almost half of the time, doctors and nurses on popular TV medical dramas respond inappropriately to seizures, suggesting that watching TV is not the best way to learn what to do if you are present when someone has a seizure...
Drama Or Reality TV: Do Medical Shows Depict Proper First Aid For Seizures?
Watching TV medical shows might not be the best way to learn what to do when someone has a seizure...
FDA Approves Once-A-Day Lamictal(R)XR(TM) As Add-On Epilepsy Therapy For Primary Generalized Tonic-Clonic Seizures
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures...
Government Cracks Down On Drug Marketing
Recent crackdown on pharmaceutical companies suggests that drug marketing remains an issue with federal authorities. The Wall Street Journal reports: "Novartis AG's agreement to settle criminal allegations involving marketing of an epilepsy drug is the latest in a string of cases showing that improper marketing practices are still a problem years after the U.S...
Non-invasive Testing, Earlier Surgery Can Stop Seizures In Tuberous Sclerosis Complex
When medication fails to control seizures in children with tuberous sclerosis complex (TSC), a rare genetic disorder that affects multiple organ systems and frequently causes epilepsy, surgery to remove part of the brain is often necessary. But pre-surgical testing, which involves the implanting of electrodes into a child's head, can lead to longer hospital stays and greater risks from surgery...
Ginkgo Herbal Medicines May Increase Seizures In People With Epilepsy
Restrictions should be placed on the use of Ginkgo biloba (G. biloba) - a top-selling herbal remedy - because of growing scientific evidence that Ginkgo may increase the risk of seizures in people with epilepsy and could reduce the effectiveness of anti-seizure drugs, a new report concludes. The article appears in ACS' monthly Journal of Natural Products...
FDA Extends PDUFA Action Date For STEDESAâ„¢ New Drug Application
Sepracor Inc. announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESAâ„¢ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010...
Drug Therapy To Minimize Death And Disability From Traumatic Brain Injury To Be Funded At UC Davis
A clinical trial of a new neuroprotective drug for people with traumatic brain injuries will be offered to patients seen in UC Davis Medical Center's level-1 trauma center, through an $8 million grant funded by the Congressionally Directed Medical Research Program of the U.S. Department of Defense...
Tuberous Sclerosis, Commonly Associated With Autism, Linked To Defects In Axon Guidance
Studying a rare disorder known as tuberous sclerosis complex (TSC), researchers at Children's Hospital Boston add to a growing body of evidence suggesting that autism spectrum disorders, which affect 25 to 50 percent of TSC patients, result from a miswiring of connections in the developing brain, leading to improper information flow...
New Tools Use Light To Turn Off Brain Cells And Possibly Treat Brain Disorders
Neuroscientists at the Massachusetts Institute of Technology have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light. When targeted to specific neurons, they could potentially lead to new treatments for abnormal brain activity associated with disorders including chronic pain, epilepsy, brain injury and Parkinson's disease...
UV LED Therapy Shows Promising Results In Preventing Focal Seizures
Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced "seizure-like" activity in a rat epilepsy model. During the study, UV light released gamma aminobutyric acid (GABA) from the "caged" compound carbonyl amino butanoic acid (BC204). GABA then decreased the abnormal electrical activity in the CA1 area of the brain...
Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches And Increased Seizure Activity
Express Scripts, Inc. (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations...
Mylan Receives Approval For Generic Version Of Antiepileptic Keppra® 1000 Mg
Mylan Inc. (NASDAQ: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg. Levetiracetam Tablets are the generic version of UCB Pharma's antiepileptic Keppra®...
Worms Unlock Secrets To New Epilepsy Treatments
A team of scientists from The University of Alabama used worms to reel in information that they hope will lead to a greater understanding of cellular mechanisms that may be exploited to treat epilepsy. In a new research report in the journal GENETICS, the researchers explain how the transparent roundworm, C...
Pivotal Trial Data Demonstrate Neuropace RNS System Reduced Seizures In People With Epilepsy
NeuroPace, Inc. has announced that results from its pivotal trial demonstrated the RNS® System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication...
Pivotal Study Of Medtronic Deep Brain Stimulation Therapy Shows Long-Term Reduction In Seizure Rate In Patients With Severe Epilepsy
Long-term data from an investigational study of Deep Brain Stimulation (DBS) Therapy for Epilepsy was released this week by Medtronic, Inc. (NYSE: MDT) at the American Epilepsy Society Meeting (AES) in Boston...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
